Previsioni di mercato del frazionamento del plasma in Sud America fino al 2028 – Impatto del COVID-19 e analisi regionale per prodotto (immunoglobulina, albumina, concentrati di fattori di coagulazione, inibitori della proteasi e altri prodotti al plasma), applicazione (neurologia, immunologia, ematologia, terapia intensiva, pneumologia e Altre applicazioni) e Utente finale (Ospedali e cliniche, Laboratori di ricerca clinica e Istituti accademici)
Introduzione al mercato
La regione SAM per la stima del mercato per il frazionamento del plasma è composta da paesi come Brasile, Argentina e il resto della SAM. Si prevede che la regione sperimenterà opportunità di crescita a causa della crescente incidenza di ictus nei paesi e dell’aumento dello sviluppo dei sistemi sanitari. Si prevede che il mercato crescerà anche a causa della crescente consapevolezza sui tumori e sugli aneurismi cerebrali nei paesi della regione.
C\'è stato un aumento del numero di casi in Paesi SAM dallo scoppio della seconda ondata di COVID-19. Secondo il Consiglio Internazionale degli Infermieri, a causa dell’elevata trasmissione del virus, il numero di decessi tra gli operatori sanitari in Brasile è più elevato che in altre nazioni. Attualmente, i paesi della SAM stanno rapidamente aumentando i loro programmi clinici per combattere il COVID-19. In questo scenario, le aziende farmaceutiche e biofarmaceutiche stanno enfatizzando lo sviluppo di nuove terapie terapeutiche per il trattamento di COVID-19, che sta incidendo negativamente sul mercato. Inoltre, a causa dei blocchi imposti in diversi paesi della SAM, anche la fornitura di sangue e prodotti correlati è diminuita poiché le persone non potevano uscire dalle proprie case per donare. La diminuzione della fornitura di sangue ha avuto ripercussioni negative sulle aziende di lavorazione del plasma. Pertanto, è probabile che l’epidemia di COVID-19 abbia un impatto negativo sulla crescita del mercato.
Panoramica e dinamiche del mercato
Si prevede che il mercato del frazionamento del plasma nella SAM crescerà da 1.955,98 milioni di dollari nel 2021 a 2.663,87 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 4,5% dal 2021 al 2028. Gli attori del mercato associati alla metabolomica stanno esplorando attivamente le possibili tecnologie innovative per facilitare i ricercatori e le cure mediche come il plasma contenente i componenti essenziali per curare una malattia, come gli anticorpi . Sono in corso diversi studi sulle possibili applicazioni del plasma per malattie difficilmente curabili con gli approcci tradizionali. Inoltre, si prevede che la crescente consapevolezza sui vantaggi della donazione di sangue e delle applicazioni del plasma tra le persone aprirà nuove prospettive per il mercato.
Segmenti chiave del mercato
Il mercato del frazionamento del plasma SAM è segmentato in prodotto, applicazione, utente finale e paese. Il mercato del frazionamento del plasma SAM, in base al prodotto, è stato segmentato in immunoglobuline, albumina, concentrati di fattori della coagulazione, inibitori della proteasi e altri. È probabile che il segmento delle immunoglobuline deterrà la quota maggiore del mercato nel 2021. Il mercato del frazionamento del plasma SAM, in base all\'applicazione, è segmentato in neurologia, immunologia, ematologia, terapia intensiva, pneumologia e altri. Nel 2021, è probabile che il segmento Neurologia deterrà la quota maggiore del mercato. Il mercato del frazionamento del plasma SAM, in base all\'utente finale, è segmentato in ospedali e cliniche, laboratori di ricerca clinica, istituti accademici. Nel 2021, il segmento degli ospedali e delle cliniche deterrà probabilmente la quota maggiore del mercato. In base al paese, il mercato del frazionamento del plasma SAM è segmentato in Brasile, Argentina e resto della SAM. Il Brasile ha detenuto la quota di mercato maggiore nel 2021.
Principali fonti e società elencate
Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato del frazionamento del plasma in SAM sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri. Le principali aziende elencate nel rapporto sono Bharat Serums and Vaccines Limited (BSV); Laboratorio Prodotti Bio Ltd.; Biotest AG; CSL limitata; Grifols, SA; Kedrion SpA; Octapharma AG; e SK Plasma.
Motivi per acquista rapporto
- Per comprendere il panorama del mercato del frazionamento del plasma SAM e identificare i segmenti di mercato più probabilmente garantirà un forte ritorno.
- Stai al passo con la corsa comprendendo il panorama competitivo in continua evoluzione per il mercato del frazionamento del plasma SAM.
- Pianificare in modo efficiente operazioni di fusione e acquisizione e accordi di partnership nel mercato del frazionamento del plasma SAM identificando i segmenti di mercato con le vendite probabili più promettenti.
- Aiuta a prendere decisioni aziendali consapevoli e perspicaci e un\'analisi completa delle prestazioni di mercato di vari segmenti del mercato del frazionamento del plasma SAM.
- Ottieni previsioni sui ricavi di mercato per il mercato in base ai vari segmenti dal 2021 al 2028 nella regione SAM.
SAM Mercato del frazionamento del plasma Segmentazione
Mercato del frazionamento del plasma SAM - Per prodotto
- Immunoglobulina
- Immunoglobulina endovenosa (IVIG)
- Immunoglobulina sottocutanea (SCIG )
- Albumina
- Concentrati di fattori di coagulazione
- Inibitori della proteasi
- Altro
Mercato del frazionamento del plasma SAM - Per applicazione
- neurologia
- Immunologia
- Ematologia
- Area critica
- Pulmonologia
- Altri
Mercato del frazionamento del plasma SAM - Entro fine Utente
- Ospedali e cliniche
- Laboratori di ricerca clinica
- Istituti accademici
Mercato del frazionamento del plasma SAM: per paese
- Brasile
- Argentina
- Resto del il mercato del frazionamento del plasma SAM
Profili aziendali
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limited
- Grifols, SA
- Kedrion SpA
- Octapharma AG
- SK Plasma
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 SAM Plasma Fractionation Market – By Product
1.3.2 SAM Plasma Fractionation Market – By Application
1.3.3 SAM Plasma Fractionation Market – By End User
1.3.4 SAM Plasma Fractionation Market – By Country
2. SAM Plasma Fractionation Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SAM Plasma Fractionation Market – Market Landscape
4.1 Overview
4.2 SAM PEST Analysis
4.3 Experts Opinion
5. SAM Plasma Fractionation Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Plasma Therapy is Becoming More Commonly Used
5.1.2 Rising Market Developments with Active Participation of the Players
5.2 Market Restraints
5.2.1 Competition from Non-Plasma Substitutes
5.3 Future Trends
5.3.1 Various Novel Diseases Getting Treated with the Use of Plasma Therapy
5.4 Impact Analysis
6. Plasma Fractionation Market – SAM Analysis
6.1 SAM Plasma Fractionation Market Revenue Forecast and Analysis
7. SAM Plasma Fractionation Market Revenue and Forecasts To 2028– by Product
7.1 Overview
7.2 SAM Plasma Fractionation Market, By Product 2021 & 2028 (%)
7.3 Immunoglobulin
7.3.1 Overview
7.3.2 Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.1 Intravenous Immunoglobulin (IVIG)
7.3.2.1.1 Overview
7.3.2.1.2 Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.3.2.2 Subcutaneous Immunoglobulin (SCIG)
7.3.2.2.1 Overview
7.3.2.2.2 Subcutaneous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Albumin
7.4.1 Overview
7.4.2 Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Coagulation Factor Concentrates
7.5.1 Overview
7.5.2 Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Protease Inhibitors
7.6.1 Overview
7.6.2 Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Other Plasma Products
7.7.1 Overview
7.7.2 Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
8. SAM Plasma Fractionation Market Revenue and Forecasts To 2028 – Application
8.1 Overview
8.2 SAM Plasma Fractionation Market Share by Application 2021 & 2028 (%)
8.3 Neurology
8.3.1 Overview
8.3.2 Neurology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.4 Immunology
8.4.1 Overview
8.4.2 Immunology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.5 Hematology
8.5.1 Overview
8.5.2 Hematology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.6 Critical Care
8.6.1 Overview
8.6.2 Critical Care: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.7 Pulmonology
8.7.1 Overview
8.7.2 Pulmonology: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
8.8 Other Applications
8.8.1 Overview
8.8.2 Other Applications: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9. SAM Plasma Fractionation Market Revenue and Forecasts To 2028 – End User
9.1 Overview
9.2 SAM Plasma Fractionation Market Share by End User 2021 & 2028 (%)
9.3 Hospitals and Clinics
9.3.1 Overview
9.3.2 Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.4 Clinical Research Laboratories
9.4.1 Overview
9.4.2 Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
9.5 Academic Institutes
9.5.1 Overview
9.5.2 Academic Institutes: Plasma Fractionation Market Revenue and Forecast to 2028 (US$ Mn)
10. SAM Plasma Fractionation Market Revenue and Forecasts to 2028 – Country Analysis
10.1 Overview
10.1.1 SAM Plasma Fractionation Market, by Country, 2021 & 2028 (%)
10.1.1.1 Brazil: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.1 Overview
10.1.1.1.2 Brazil: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3 Brazil: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.3.1 Brazil: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.4 Brazil: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.1.5 Brazil: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2 Argentina: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.1 Overview
10.1.1.2.2 Argentina: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3 Argentina: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.3.1 Argentina: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.4 Argentina: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.2.5 Argentina: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3 Rest of SAM: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.1 Overview
10.1.1.3.2 Rest of SAM: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3 Rest of SAM: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.3.1 Rest of SAM: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.4 Rest of SAM: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
10.1.1.3.5 Rest of SAM: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
11. Impact Of COVID-19 Pandemic on SAM Plasma Fractionation Market
11.1 SAM: Impact Assessment of COVID-19 Pandemic
12. Plasma Fractionation Market–Industry Landscape
12.1 Overview
12.2 Growth Strategies Followed by Major Market Players (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic developments
12.4.1 Overview
13. Company Profiles
13.1 Biotest AG.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Octapharma AG
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Kedrion S.p.A
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 CSL Limited
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Grifols, S.A.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bio Products Laboratory Ltd.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Bharat Serums and Vaccines Limited (BSV)
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 SK Plasma
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Brazil: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 2. Brazil: Plasma Fractionation Market, by Immunoglobulin type – Revenue and Forecast to 2028 (USD Million)
Table 3. Brazil: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 4. Brazil: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. Argentina: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 6. Argentina: Plasma Fractionation Market, by Immunoglobulin Type– Revenue and Forecast to 2028 (USD Million)
Table 7. Argentina: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 8. Argentina: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Rest of SAM: Plasma Fractionation Market, by Product – Revenue and Forecast to 2028 (US$ Million)
Table 10. Rest of SAM: Plasma Fractionation Market, by Immunoglobulin Type – Revenue and Forecast to 2028 (US$ Million)
Table 11. Rest of SAM: Plasma Fractionation Market, by Application – Revenue and Forecast to 2028 (US$ Million)
Table 12. Rest of SAM: Plasma Fractionation Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Organic Developments Done By Companies
Table 14. Inorganic developments done by Companies
Table 15. Glossary of Terms, SAM Plasma Fractionation Market
LIST OF FIGURES
Figure 1. SAM Plasma Fractionation Market Segmentation
Figure 2. SAM Plasma Fractionation Market Segmentation, By Country
Figure 3. SAM Plasma Fractionation Market Overview
Figure 4. Immunoglobulin Segment Held the Largest Share of the Product Segment in SAM Plasma Fractionation Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. SAM PEST Analysis
Figure 7. Impact Analysis of Drivers and Restraints Pertaining to SAM Plasma Fractionation Market
Figure 8. SAM Plasma Fractionation Market – Revenue Forecast and Analysis – 2019- 2028
Figure 9. SAM Plasma Fractionation Market, by Product 2021 & 2028 (%)
Figure 10. SAM Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. SAM Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. SAM Intravenous Immunoglobulin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. SAM Albumin: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. SAM Coagulation Factor Concentrates: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. SAM Protease Inhibitors: Plasma Fractionation Market Revenue and Forecasts to 2028(US$ Mn)
Figure 16. SAM Other Plasma Products: Plasma Fractionation Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. SAM Plasma Fractionation Market Share by Application 2021 & 2028 (%)
Figure 18. SAM Neurology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 19. SAM Immunology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 20. SAM Hematology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 21. SAM Critical Care: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 22. SAM Pulmonology: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 23. SAM Other Applications: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 24. SAM Plasma Fractionation Market Share by End User 2021 & 2028 (%)
Figure 25. SAM Hospitals and Clinics: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 26. SAM Clinical Research Laboratories: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 27. SAM Academic Institutes: Plasma Fractionation Market Revenue and Forecasts To 2028 (US$ Mn)
Figure 28. SAM: Plasma Fractionation Market, By Key Country – Revenue (2021) (USD Million)
Figure 29. SAM: Plasma Fractionation Market, by Country, 2021 & 2028 (%)
Figure 30. Brazil: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 31. Argentina: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 32. Rest of SAM: Plasma Fractionation Market– Revenue and Forecast to 2028 (US$ Million)
Figure 33. Impact of COVID-19 Pandemic in SAM Market
Figure 34. Growth Strategies Followed by Major Market Players (%)
- Bharat Serums and Vaccines Limited (BSV)
- Bio Products Laboratory Ltd.
- Biotest AG.
- CSL Limited
- Grifols, S.A.
- Kedrion S.p.A
- Octapharma AG
- SK Plasma
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the SAM plasma fractionation market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the SAM plasma fractionation market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth SAM market trends and outlook coupled with the factors driving the plasma fractionation market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution